Publications

Detailed Information

Expansion of myeloid-derived suppressor cells correlates with renal progression in type 2 diabetic nephropathy

DC Field Value Language
dc.contributor.authorIslam, Jahirul-
dc.contributor.authorLee, Hack June-
dc.contributor.authorYang, Seung Hee-
dc.contributor.authorKim, Dong Ki-
dc.contributor.authorJoo, Kwon Wook-
dc.contributor.authorKim, Yon Su-
dc.contributor.authorSeo, Sang-Uk-
dc.contributor.authorSeong, Seung-Yong-
dc.contributor.authorLee, Dong-Sup-
dc.contributor.authorYoun, Je-In-
dc.contributor.authorHan, Seung Seok-
dc.date.accessioned2023-07-21T07:01:30Z-
dc.date.available2023-07-21T07:01:30Z-
dc.date.created2020-05-25-
dc.date.created2020-05-25-
dc.date.created2020-05-25-
dc.date.issued2020-04-
dc.identifier.citationImmune Network, Vol.20 No.2, p. e18-
dc.identifier.issn1598-2629-
dc.identifier.urihttps://hdl.handle.net/10371/195233-
dc.description.abstractType 2 diabetic nephropathy (T2DN) progresses with an increasingly inflammatory milieu, wherein various immune cells are relevant. Herein, we investigated the levels of myeloid-derived suppressor cells (MDSCs) and their clinical implication in patients with T2DN. A total of 91 subjects (T2DN, n=80; healthy, n=11) were recruited and their PBMCs were used for flow cytometric analysis of polymorphonuclear (PMN-) and monocytic (M-) MDSCs, in addition to other immune cell subsets. The risk of renal progression was evaluated according to the quartiles of MDSC levels using the Cox model. The proportion of MDSCs in T2DN patients was higher than in healthy individuals (median, 6.7% vs. 2.5%). PMN-MDSCs accounted for 96% of MDSCs, and 78% of PMN-MDSCs expressed Lox-1. The expansion of PMN-MDSCs was not related to the stage of T2DN or other kidney disease parameters such as glomerular filtration rate and proteinuria. The production of ROS in PMN-MDSCs of patients was higher than in neutrophils of patients or in immune cells of healthy individuals, and this production was augmented under hyperglycemic conditions. The 4th quartile group of PMN-MDSCs had a higher risk of renal progression than the 1st quartile group, irrespective of adjusting for multiple clinical and laboratory variables. In conclusion, PMN-MDSCs are expanded in patients with T2DN, and may represent as an immunological biomarker of renal progression.-
dc.language영어-
dc.publisher대한면역학회-
dc.titleExpansion of myeloid-derived suppressor cells correlates with renal progression in type 2 diabetic nephropathy-
dc.typeArticle-
dc.identifier.doi10.4110/in.2020.20.e18-
dc.citation.journaltitleImmune Network-
dc.identifier.wosid000530632100007-
dc.identifier.scopusid2-s2.0-85084193527-
dc.citation.number2-
dc.citation.startpagee18-
dc.citation.volume20-
dc.identifier.kciidART002583652-
dc.description.isOpenAccessY-
dc.contributor.affiliatedAuthorKim, Dong Ki-
dc.contributor.affiliatedAuthorJoo, Kwon Wook-
dc.contributor.affiliatedAuthorKim, Yon Su-
dc.contributor.affiliatedAuthorSeo, Sang-Uk-
dc.contributor.affiliatedAuthorSeong, Seung-Yong-
dc.contributor.affiliatedAuthorLee, Dong-Sup-
dc.contributor.affiliatedAuthorYoun, Je-In-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.subject.keywordPlusDISEASE-
dc.subject.keywordPlusMELLITUS-
dc.subject.keywordAuthorDiabetic nephropathy-
dc.subject.keywordAuthorEnd-stage renal disease-
dc.subject.keywordAuthorImmunology-
dc.subject.keywordAuthorMonocyte-
dc.subject.keywordAuthorMyeloid-derived suppressor cell-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Related Researcher

  • College of Medicine
  • Department of Medicine
Research Area Nephrology, Transplantation, Urology

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share